Clinical Trial

Quercus Ilex and Quercus Robur Allergen Extracts Standardisation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to determine the biological activity of Quercus illex and Quercus robur allergen extracts in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-09-05; most recent amendment 2025-04-30.
Status change: Not Yet Recruiting → Recruiting 2024-09-16
Trial Details
NCT Number NCT05532566
Lead Sponsor Inmunotek S.L.
Conditions Allergic Reaction, Allergic Skin Reaction, Allergy Pollen
Enrollment 30 participants
Start Date 2023-01-24
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-01